Arch Therapeutics, Inc. (OTCMKTS:ARTH – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.63 and traded as low as $0.32. Arch Therapeutics shares last traded at $0.53, with a volume of 37,626 shares traded.
Arch Therapeutics Stock Down 8.9 %
The stock has a 50 day moving average price of $0.62 and a 200-day moving average price of $1.01.
Arch Therapeutics (OTCMKTS:ARTH – Get Free Report) last announced its earnings results on Monday, August 19th. The biotechnology company reported ($1.44) earnings per share (EPS) for the quarter. The business had revenue of $0.03 million during the quarter.
About Arch Therapeutics
Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.
Read More
- Five stocks we like better than Arch Therapeutics
- How to Calculate Inflation Rate
- When Is the Best Time to Invest in Mutual Funds?
- Most active stocks: Dollar volume vs share volume
- Is NVIDIA Stock in a Correction or Consolidation?
- What Are Dividends? Buy the Best Dividend Stocks
- 3 Oversold Stocks with Big RSI Rebound Potential
Receive News & Ratings for Arch Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
